We are live on ! Find out more
CRMD icon

CorMedix
CRMD

47 hedge funds and large institutions have $11.6M invested in CorMedix in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.08% less ownership

Funds ownership: 4.29% → 3.21% (-1.1%)

13% less funds holding

Funds holding: 54 → 47 (-7)

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

39% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 18

44% less capital invested

Capital invested by funds: $20.5M → $11.6M (-$8.98M)

95% less call options, than puts

Call options by funds: $41K | Put options by funds: $906K

Holders
47
Holders Change
-7
Holders Change %
-12.96%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
11
Reduced
18
Closed
18
Calls
$41K
Puts
$906K
Net Calls
-$865K
Net Calls Change
+$351K

Top Buyers

Rank Fund Capital Flow
1
PP
Paloma Partners
Connecticut
+$357K
2
Millennium Management
Millennium Management
New York
+$292K
3
CS
Credit Suisse
Switzerland
+$283K
4
ARTA
A.R.T. Advisors
New York
+$144K
5
Squarepoint
Squarepoint
New York
+$139K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$2.54M
2
Northern Trust
Northern Trust
Illinois
-$989K
3
State Street
State Street
Massachusetts
-$878K
4
BIT
BlackRock Institutional Trust
California
-$763K
5
BIM
BlackRock Investment Management
Delaware
-$360K

CRMD Hedge Fund Activity: Q2 2016 in Review

47 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2016, worth a combined $11.6M — down 44% from $20.5M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CRMD and 11 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 11 added.

The largest buyer was Paloma Partners, adding an estimated $357K. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.54M.

  • 47 institutional investors held CorMedix (CRMD) as of Q2 2016, down from 54 in Q1 2016.
  • Funds reported $11.6M of CorMedix stock for Q2 2016, down 44% quarter-over-quarter.
  • 11 funds opened new CorMedix positions in Q2 2016 and 18 closed out, a net change of -7 holders.
  • The largest CorMedix buyer in Q2 2016 was Paloma Partners, an estimated $357K added.
  • The largest CorMedix seller in Q2 2016 was BlackRock Fund Advisors, an estimated $2.54M sold.

Based on aggregated 13F filings for Q2 2016.